Literature DB >> 10477721

Rapid differentiation of a rare subset of adult human lin(-)CD34(-)CD38(-) cells stimulated by multiple growth factors in vitro.

T Fujisaki1, M G Berger, S Rose-John, C J Eaves.   

Abstract

Recently, several reports of lineage-negative (lin(-)) CD34(-) cells with in vivo hematopoietic activity have focused interest on the properties and growth factor response characteristics of these cells. We have now identified a combination of 5 growth factors that are necessary and sufficient to stimulate a marked mitogenic and differentiation response by a subset of human lin(-)CD34(-)CD38(-) cells present in normal adult human marrow and granulocyte colony-stimulating factor (G-CSF)-mobilized blood. Less than 0.1% of the cells in highly purified (including doubly sorted) lin(-)CD34(-)CD38(-) cells from these 2 sources formed colonies directly in semisolid medium or generated such cells after 6 weeks in long-term culture. Nevertheless, approximately 1% of the same lin(-)CD34(-)CD38(-) cells were able to proliferate rapidly in serum-free liquid suspension cultures containing human flt-3 ligand, Steel factor, thrombopoietin, interleukin-3 (IL-3), and hyper-IL-6 to produce a net 28- +/- 8-fold increase in total cells within 10 days. Of the cells present in these 10-day cultures, 5% +/- 2% were CD34(+) and 2.5% +/- 0.9% were erythroid, granulopoietic, megakaryocytopoietic, or multilineage colony-forming cells (CFC) (13 +/- 7 CFC per lin(-)CD34(-)CD38(-) pre-CFC). In contrast to lin(-)CD34(+)CD38(-) cells, this response of lin(-)CD34(-)CD38(-) cells required exposure to all of the 5 growth factors used. Up to 1.7 x 10(5) lin(-)CD34(-) adult marrow cells failed to engraft sublethally irradiated NOD/SCID-beta(2)M(-/-) mice. These studies demonstrate unique properties of a rare subset of lin(-)CD34(-)CD38(-) cells present in both adult human marrow and mobilized blood samples that allow their rapid proliferation and differentiation in vitro within an overall period of 3 to 4 weeks. The rapidity of this response challenges current concepts about the normal duration and coordinated control of these processes in adults.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477721

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  Human CD34- hematopoietic stem cells: basic features and clinical relevance.

Authors:  Kiyoshi Ando
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

2.  Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype.

Authors:  N Uchida; T Fujisaki; A C Eaves; C J Eaves
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  C1qRp defines a new human stem cell population with hematopoietic and hepatic potential.

Authors:  Guenahel H Danet; Jennifer L Luongo; Gary Butler; Min Min Lu; Andrea J Tenner; M Celeste Simon; Dominique A Bonnet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-24       Impact factor: 11.205

4.  Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle.

Authors:  Yvan Torrente; Marzia Belicchi; Maurilio Sampaolesi; Federica Pisati; Mirella Meregalli; Giuseppe D'Antona; Rossana Tonlorenzi; Laura Porretti; Manuela Gavina; Kamel Mamchaoui; Maria Antonietta Pellegrino; Denis Furling; Vincent Mouly; Gillian S Butler-Browne; Roberto Bottinelli; Giulio Cossu; Nereo Bresolin
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.